Sawai Pharmaceutical Co. Ltd. | Ownership
Companies that own Sawai Pharmaceutical Co. Ltd.
Sompo Japan Nipponkoa Asset Management Co., Ltd.
2,331,700
5.29%
391,800
4.51%
11/15/2017
The Vanguard Group, Inc.
1,085,294
2.46%
27,500
0%
07/31/2018
Azimut Capital Management SGR SpA
906,300
2.06%
234,000
0.75%
06/30/2017
Nomura Asset Management Co., Ltd.
847,696
1.92%
72,896
0.03%
07/31/2018
Nissay Asset Management Corp.
829,700
1.88%
-189,097
0.23%
02/20/2017
Dimensional Fund Advisors LP
574,300
1.3%
79,400
0.01%
04/30/2018
APG Asset Management NV
476,125
1.08%
38,792
0.02%
03/31/2018
Baillie Gifford & Co.
473,900
1.08%
72,700
0.02%
04/30/2018
Daiwa Asset Management Co. Ltd.
464,400
1.05%
114,800
0.03%
07/31/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
463,300
1.05%
275,000
0.05%
05/28/2018
| Address |
5-2-30 Miyahara
Osaka Osaka 532
Japan
|
|
Employees
|
- |
| Website |
http://www.sawai.co.jp |
| Updated |
07/08/2019 |
| Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. |
